Nasdaq - Delayed Quote USD

Franklin Biotechnology Discovery Adv (FTDZX)

153.17 +1.54 (+1.02%)
At close: 8:01 PM EDT
Loading Chart for FTDZX
DELL
  • Previous Close 151.63
  • YTD Return 16.62%
  • Expense Ratio 0.80%
  • Category Health
  • Last Cap Gain 39.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 924.78M
  • Beta (5Y Monthly) 0.70
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 35.87%
  • Last Dividend 0.42
  • Inception Date Mar 4, 2014

Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

Franklin Templeton Investments

Fund Family

Health

Fund Category

924.78M

Net Assets

2014-03-04

Inception Date

Performance Overview: FTDZX

View More

Trailing returns as of 10/31/2024. Category is Health.

YTD Return

FTDZX
16.62%
Category
7.95%
?

1-Year Return

FTDZX
36.91%
Category
30.16%
?

3-Year Return

FTDZX
3.42%
Category
16.10%
?

5-Year Return

FTDZX
10.59%
Category
15.71%
?

People Also Watch

Holdings: FTDZX

View More

Top 10 Holdings (42.03% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 8.08%
REGN
Regeneron Pharmaceuticals, Inc. 7.07%
VRTX
Vertex Pharmaceuticals Incorporated 5.77%
INSM
Insmed Incorporated 3.78%
GILD
Gilead Sciences, Inc. 3.66%
AZN
AstraZeneca PLC 2.83%
ITCI
Intra-Cellular Therapies, Inc. 2.81%
BIIB
Biogen Inc. 2.71%
MRUS
Merus N.V. 2.70%
ARGX
argenx SE 2.61%

Sector Weightings

Recent News: FTDZX

View More

Research Reports: FTDZX

View More

Top Mutual Funds